Very few data are available on the comparison of infectious complications in peripheral blood stem cell transplantation (PBSCT) and bone marrow transplant (BMT). The objective of this study was to evaluate the severity and frequency of infectious complications in patients randomized to receive PBSCT or BMT. We retrospectively reviewed the charts of all patients included in a randomized clinical trial comparing PBSCT (27 patients) and BMT (29 patients). We analyzed two periods: pre-engraftment and post-engraftment. In the pre-engraftment period, we compared the two groups with respect to the duration of neutropenia, antibiotic use and hospitalization, and documentation of infection. In the post-engraftment period, we analyzed the occurrence and severity of graft-versus-host disease (GVHD), duration of cyclosporine, corticosteroids, antibiotic, antiviral and antifungal prophylaxis, number of episodes of infection, and death rates. Patients receiving PBSCT had shorter duration of neutropenia, but there were no differences in the incidence of infections or duration of antibiotic therapy. Patients receiving PBSCT had a higher incidence of extensive chronic GVHD (65% vs. 39%, P = 0.08), longer duration of cyclosporine use (risk ratio [RR] 1.97), corticosteroids (RR 1.66), antibacterial (RR 2.60), antifungal (RR 2.50), anti-Pneumocystis carinii (RR 2.06) and anti-cytomegalovirus (RR 1.44) prophylaxis, and more infectious episodes (3.65 vs. 2.32 per 1000 days at risk, RR 1.57). There were no differences in death rates. Multivariate analysis identified the use of steroids as the most significant variable associated with infectious episodes. PBSCT was associated with more infections in the post-engraftment period. Copyright © Blackwell Munksgaard 2003.54167173Azevedo, W.M., Aranha, F.J., Gouvea, J.V., Allogeneic transplantation with blood stem cells mobilized by rhG-CSF for hematological malignancies (1995) Bone Marrow Transplant, 16, pp. 647-653Bensinger, W.I., Clift, R., Martin, P., Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation (1996) Blood, 88, pp. 2794-2800Pavletic, Z.S., Bishop, M.R., Tarantolo, S.R., Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies (1997) J Clin Oncol, 15, pp. 1608-1616Lemoli, R.M., Bandini, G., Leopardi, G., Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: A retrospective comparison of short-term outcome with bone marrow transplantation (1998) Haematologica, 83, pp. 48-55Bacigalupo, A., Zikos, P., Van Lint, M.T., Allogeneic bone marrow or peripheral blood cell transplants in adults with hematologic malignancies: A single-center experience (1998) Exp Hematol, 26, pp. 409-414Scott, M.A., Gandhi, M.K., Jestice, H.K., Mahendra, P., Bass, G., Marcus, R.E., A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: A case controlled study (1998) Bone Marrow Transplant, 22, pp. 273-276Solano, C., Martinez, C., Brunet, S., Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study (1998) Bone Marrow Transplant, 22, pp. 1129-1135. , Spanish Group of Allo-PBTUstun, C., Arslan, O., Beksac, M., A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: A focus on the incidence of graft-vs.-host disease and relapse (1999) Biol Blood Marrow Transplant, 5, pp. 28-35Russell, J.A., Larratt, L., Brown, C., Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: Influence of stem cell source on outcome (1999) Bone Marrow Transplant, 24, pp. 1177-1183Powles, R., Mehta, J., Kulkarni, S., Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: A randomised trial (2000) Lancet, 355, pp. 1231-1237Champlin, R.E., Schmitz, N., Horowitz, M.M., Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation (2000) Blood, 95, pp. 3702-3709. , IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT)Blaise, D., Kuentz, M., Fortanter, C., Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: A report from the Societe Francaise de Greffe de Moelle (2000) J Clin Oncol, 18, pp. 537-546Bensinger, W.I., Martin, P.J., Stoker, B., Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers (2001) N Engl J Med, 344, pp. 175-181Remberger, M., Ringden, O., Blau, I.W., No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors (2001) Blood, 98, pp. 1739-1745Vigorito, A.C., Marques Jr., J.F., Aranha, F.J., Oliveira, G.B., Miranda, E.C., De Souza, C.A., A randomized, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of hematologic malignancies: An update (2001) Haematologica, 86, pp. 665-666Guardiola, P., Runde, V., Bacigalupo, A., Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes (2002) Blood, 99, pp. 4370-4378Schmitz, N., Bacigalupo, A., Hasenclever, D., Allogeneic bone marrow transplantation vs. filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: First results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation (1998) Bone Marrow Transplant, 21, pp. 995-1003Couban, S., Simpson, D.R., Barnett, M.J., A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies (2002) Blood, 100, pp. 1525-1531Morton, J., Hutchins, C., Durrant, S., Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: Significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells (2001) Blood, 98, pp. 3186-3191Schmitz, N., Beksac, M., Hasenclever, D., Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia (2002) Blood, 100, pp. 761-767Cutler, C., Giri, S., Jeyapalan, S., Paniagua, D., Viswanathan, A., Antin, J.H., Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: A meta-analysis (2001) J Clin Oncol, 19, pp. 3685-3691Flowers, M.E., Parker, P.M., Johnston, L.J., Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: Long-term follow-up of a randomized trial (2002) Blood, 100, pp. 415-419Storek, J., Dawson, M.A., Storer, B., Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation (2001) Blood, 97, pp. 3380-3389Wlngard, J.R., Opportunistic infections after blood and marrow transplantation (1999) Transpl Infect Dis, 1, pp. 3-20Vigorito, A.C., Azevedo, W.M., Marques, J.F., A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies (1998) Bone Marrow Transplant, 22, pp. 1145-1151The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel (1990) J Infect Dis, 161, pp. 397-401Ascioglu, S., Rex, J.H., De Pauw, B., Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus (2002) Clin Infect Dis, 34, pp. 7-14Nucci, M., Spector, N., Bueno, A.P., Risk factors and attributable mortality associated with superinfections in neutropenic patients with cancer (1997) Clin Infect Dis, 24, pp. 575-579Heldal, D., Tjonnfjord, G., Brinch, L., A randomised study of allogeneic transplantation with stem cells from blood or bone marrow (2000) Bone Marrow Transplant, 25, pp. 1129-1136Mahmoud, H., Fahmy, O., Kamel, A., Kamel, M., El Haddad, A., El Kadi, D., Peripheral blood vs. bone marrow as a source for allogeneic hematopoietic stem cell transplantation (1999) Bone Marrow Transplant, 24, pp. 355-358Nivison-Smith, I., Bradstock, K.F., Szer, J., Allogeneic haemopoietic cell transplants in Australia, 1996 - A multi-centre retrospective comparison of the use of peripheral blood stem cells with bone marrow (2001) Bone Marrow Transplant, 28, pp. 21-27Ringden, O., Remberger, M., Runde, V., Faster engraftment of neutrophils and platelets with peripheral blood stem cells from unrelated donors: A comparison with marrow transplantation (2000) Bone Marrow Transplant, 25 (SUPPL. 2), pp. S6-S8Serody, J.S., Sparks, S.D., Lin, Y., Comparison of granulocyte colony-stimulating factor (G-CSF) - Mobilized peripheral blood progenitor cells and G-CSF-stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation (2000) Biol Blood Marrow Transplant, 6, pp. 434-440Hagglund, H., Ringden, O., Remberger, M., Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donors, compared to bone marrow (1998) Bone Marrow Transplant, 22, pp. 131-136Lokhorst, H.M., Meuwissen, O.J., Bast, E.J., Dekker, A.W., VAD chemotherapy for refractory multiple myeloma (1989) Br J Haematol, 71, pp. 25-30Anaissie, E.J., Kontoyiannis, D.P., O'Brien, S., Infections in patients with chronic lymphocytic leukemia treated with fludarabine (1998) Ann Intern Med, 129, pp. 559-566Wald, A., Leisenring, W., Van Burikj, A., Bowden, R.A., Epidemiology of Aspergillis infections in a large cohort of patients undergoing bone marrow transplantation (1997) J Infect Dis, 175, pp. 1459-1466Ribaud, P., Chastang, C., Latge, J.P., Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation (1999) Clin Infect Dis, 28, pp. 322-330